Global Angle-Closure Glaucoma Market By Diagnosis (Gonioscopy, Tonometry, Ophthalmoscopy, Others), Treatment (Surgery, Medication, Others), Route of Administration (Oral, Parenteral, Ocular, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Angle-Closure Glaucoma Market
Angle-closure glaucoma market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned research forecast period. Rising prevalence of eye related disorders worldwide and emerging markets are the factors responsible for the growth of this market.
Growing cases of glaucoma drives the angle-closure glaucoma market. Due to family history of eye diseases, presence of disease condition such as cataracts, tumors, diabetic retinopathy & other eye related disorders also boost up the angle-closure glaucoma market growth. However, increased advancement in the treatment of eye diseases and rise in geriatric population with eye diseases worldwide will boost up the market. But, stringent FDA guidelines for the drug approval of new drug may hamper the global angle-closure glaucoma market.
Angle-closure glaucoma is the condition that causes fluid pressure build up inside the eyes, this fluid pressure called as intraocular pressure. In the normal eye fluid drains out from eye through system of canals. These canals present in a mesh of tissue between iris and cornea, when they both iris & cornea) come closure, this will close the angle between them. This process blocks the canal and stops the fluid flowing through them. By this process intraocular pressure generated which can damage the optic nerves or loss of vision completely if not treated early.
This angle-closure glaucoma market report provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Angle-Closure Glaucoma Market Scope and Market Size
The angle-closure glaucoma market is segmented on the basis of diagnosis, treatment, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of diagnosis, the angle-closure glaucoma market is segmented into gonioscopy, tonometry, ophthalmoscopy and others.
- The treatment for angle-closure glaucoma market includes surgery, medication and others. Surgery further divided into peripheral iridotomy, surgical iridectomy and others. Medication segment further divided into beta blockers, carbonic anhydrase inhibitors, cholinergic drugs, steroids and others.
- Route of administration segment of angle-closure glaucoma market is segmented into oral and parenteral, ocular and others.
- On the basis of end-users, the angle-closure glaucoma market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the angle-closure glaucoma market has also been segmented into hospital pharmacy, retail pharmacy others.
Angle-Closure Glaucoma Market Country Level Analysis
Angle-closure glaucoma are analysed and market size information is provided by country, diagnosis, treatment, route of administration, end-users and distribution channel as referenced above.
The countries covered in the angle-closure glaucoma market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, in the Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America accounts for the largest market share due to the presence of key manufacturer of the product, high research and development and healthcare expenditure and skilled professionals. Europe is considered second largest market for angle-closure glaucoma due to increased ophthalmic surgeries. Asia-Pacific is expected to account for the largest market share over coming years for the angle-closure glaucoma market due to increased government awareness programs and number of generic drugs.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Angle-closure glaucoma market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Angle-Closure Glaucoma Market Share Analysis
Angle-closure glaucoma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to angle-closure glaucoma market.
The major players covered in the angle-closure glaucoma market are Taro Pharmaceutical Industries Ltd., Novartis AG, ALLERGAN, Akorn Pharmaceuticals, Bausch & Lomb Incorporated., Aerie Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-